TCR2 Therapeutics' GAAP loss for 2021 was $99.807 million, up 48.7% from $67.124 million the previous year.
TCR2 Therapeutics' GAAP loss for 2021 was $99.807 million, up 48.7% from $67.124 million the previous year.
TCR2 Therapeutics reports for 2021
TCR2 Therapeutics' GAAP loss for 2021 was $99.807 million, up 48.7% from $67.124 million the previous year. Source: 
investors.tcr2.com
investors.tcr2.com News feed
English (US) 